Clinical Trials in Colorado

Showing 3501-3520 of 8,657 trials

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

NCT02600429

The objective of this study is to assess the safety and efficacy of RGN-259 Ophthalmic Solution compared to placebo for the treatment of NK.

Neurotrophic Keratopathy

ReGenTree, LLC18 participantsStarted Sep 2015

Lancaster, California, United States • Colorado Springs, Colorado, United States • Fort Collins, Colorado, United States +8 more locations

UNKNOWNPhase 243 miles

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain

NCT05470608

This is a multicenter, randomized, double-blind, placebo-controlled, single ascending dose escalation study to assess the safety and efficacy of single treatment exposure of an injectable formulation of SL-1002 for the treatment of knee pain associated with osteoarthritis. Phase A of the study will enroll 3 cohorts of 8 patients per cohort, for a total of 24 patients. Patients will be randomized to receive either SL-1002 or placebo in a 3:1 ratio within each given cohort. Phase B of the study will enroll a minimum of 92 up to a maximum of 108 patients. Patients will be randomized to receive either SL-1002 or placebo in a 3:1 ratio at the recommended dose determined from Phase A. The study period will be up to 168 days inclusive of a screening period of up to 28 days.

Osteoarthritis, Knee Pain

Saol Therapeutics Inc132 participantsStarted Jun 2022

Greenwood Village, Colorado, United States • Washington D.C., District of Columbia, United States • Coral Gables, Florida, United States +12 more locations

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain

Find Trials by Condition in Colorado

A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis

Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Low-Dose Atropine for Treatment of Myopia

Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

High Dose IL 2 and Entinostat in RCC

Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Intermittent Hypoxia and Caffeine in Infants Born Preterm

Phase 2 Clinical Trial of CartiLife® in the United States

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2